Look for us at the Monarch Joint Venture Annual Conference Nov 7-9, 2017

Board of Directors

Susan Dunlap — has served as CEO since Aerulean's inception in July 2004. She began working on the intellectual property now serving as the foundation for Aerulean in 2001. She received a grant from the USDA in 2009 to build on the primary botanical discovery she made. Her full CV is here.

Ms. Dunlap's Current Activity:

Butterflies in Mind - Perennials
available on iBooks

  • designed to help you attract and feed butterflies
  • page tome that associates perennials with every US butterfly they attract
  • correlates 200+ genera with all 609 nectar-feeding US butterflies
  • contains helpful information about each plant, a list of the butterflies they attract, is abundantly illustrated, and fully indexed

Recent Awards:

  • U.S. Patent Awarded for System and Method for Plant Selection
  • US Patent Awarded for System and Method for Plant Identification
    • Patents awarded to Ms. Dunlap for her novel discovery of a new method to identify plants. Patent related research and contributing photographic work conducted by Ms. Dunlap between 1989-2014.
    • Related plant software launched 2013, aerulean.com
    • Related plant software launched 2015, findplants.net
  • Novel compilation of 1800+ nectar plants correlated with extant US adult butterflies. Awards related to this work:
    • US Copyright, 2017
  • Monarch Joint Venture, nation-wide monarch conservation group
    • New Partner, 2017
    • Attended Annual Partnership Meeting, Nov 2017
    • Nation-wide Monarch conservation group

Upcoming:

  • California Native Plant Society Annual Conference, February 2018 Ms. Dunlap will give two talks:
    • Plant ID - how it works and how it benefits the sciences
    • Visual data in Photographs - Photographs that Matter

Recent Activity:

Dr. Condoravdi — joined the Board in July 2004. She has expertise in managing large projects and identifying and resolving communication issues. Condoravdi joined the Stanford University Department of Linguistics as a research professor in 2013. Between 1999 and 2012 she was a research linguist at a major research center in California. She has had numerous speaking engagements in the United States, Europe and Japan, and is widely published in her field. Previously, Dr. Condoravdi worked at Techknowledge Corporation, a leading technical training corporation. She received an MS from Yale University in 1988 and a Ph.D. in linguistics from Stanford University in 1994.

Martin Schneider — joined the board in December 2011. He was a Program Manager with the Hughes Aircraft Company and has broad experience managing programs and dealing with U. S. and foreign governments and companies. After leaving Hughes, he started his own business consulting company servicing small to medium size companies. Although versatile in the services offered, he specialized in cost improvements and net worth evaluations. Mr. Schneider brings practical management experience to the Aerulean Board.

Dr. R. Paul Kiparsky — joined the board in July 2004. Dr. Kiparsky is the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences at Stanford University, where he has been a Professor of Linguistics since 1984. Dr. Kiparsky will help manage the translation issues Aerulean will encounter as it expands into worldwide markets. In addition to Dr. Kiparsky’s technical and educational expertise, he contributes a strong commitment to the social value of Aerulean’s products and a life-long personal interest in botany. Dr. Kiparsky received a Ph.D. in linguistics in 1965 from MIT, where he was a Professor of Linguistics between 1972 and 1984. He has received numerous honors and awards in his field, and has spoken and published worldwide.

Manuela Kogon, M.D. — joined the Board in 2010. She is an advisor to small and medium size companies, assisting them with business development, strategic planning, marketing and day-to-day operations. She started her business career as an active participant in the formulation and operation of several small businesses and translated that early experience into her current advisory role. She holds a medical degree from Basel University School of Medicine.

Dr. Cynthia R. Moore — joined the Board in 2010. Dr. Moore received a Ph.D. in Biophysical Chemistry from the University of Virginia in 1989, and a J.D. from Seton Hall University School of Law in 1998. She is a patent attorney with Moore Patents, a firm she founded in 2003, preparing and prosecuting patents and drafting opinions, primarily in the areas of chemicals, pharmaceuticals, and biotechnology.